Tumor mutational burden as a predictor of immune-related adverse events in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors: a Brief Report

作者：Federica Pecci, Xinan Wang, Valentina Santo, Eleonora Gariazzo, Edoardo Garbo, Francesco Paoloni, Guilherme Rossato de Almeida, Mihaela Aldea, Alessandro Di Federico, J. Alessi, Stephanie Canty, Giulia Bruschi, William Lotter, Mark M. Awad, Alexander Gusev, Narjust Florez, David C. Christiani, Scott J. Rodig, Mizuki Nishino, Pasi A. Jänne, Elad Sharon, Biagio Ricciuti · 发表于：Journal of Thoracic Oncology · 年份：2026 · DOI：10.1016/j.jtho.2026.104136 · 研究领域：Cancer Immunotherapy and Biomarkers、Lung Cancer Treatments and Mutations、Multiple and Secondary Primary Cancers